B3_website_language_Approved_16AUG2019

INTEGREVIEW IRB August 16, 2019 APPROVED

Biometry Precision & Agreement Study (B3) Why we are doing this study: This study will be evaluating the accuracy and precision of a new investigational imaging device that measures the dimensions of the structures inside the eye in various populations. Who can be in the study? You may be eligible to participate if you are 22 years of age or over and have: • Eyes with open angles • Or eyes with narrow angles. Further screening questions will be asked prior to scheduling an appointment. What the study involves: Participants will be screened with assessments typical of an eye examination (including dilation) to verify that the eye(s) meet the requirements to be grouped in one of the categories being studied. Eligible participants will have one eye scanned by each of the 3 investigational imaging devices as well as by 3 other FDA approved devices. The entire visit is expected to take up to 4 hours and may be split over 2 visits if necessary.

Will you directly benefit from the study? There is not expected to be any direct benefit. Other things you should know about the study: Participants will be compensated up to $300.

Principal Investigator: Mitchell Dul, OD For more information, contact the Clinical Vision Research Center